These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Schistosomiasis vaccines: where do we stand? Tebeje BM; Harvie M; You H; Loukas A; McManus DP Parasit Vectors; 2016 Sep; 9(1):528. PubMed ID: 27716365 [TBL] [Abstract][Full Text] [Related]
4. [Variations in human parasitic diseases: malaria and schistosomiasis (author's transl)]. Garin JP Bull Soc Pathol Exot Filiales; 1981; 74(6):739-49. PubMed ID: 7343140 [TBL] [Abstract][Full Text] [Related]
5. Relevance of a partial immunity-inducing anti-schistosomiasis vaccine in endemic areas. el Ridi R J Parasitol; 1995 Feb; 81(1):104. PubMed ID: 7876961 [No Abstract] [Full Text] [Related]
6. Schistosomiasis. Infection versus disease and hypersensitivity versus immunity. Cheever AW Am J Pathol; 1993 Mar; 142(3):699-702. PubMed ID: 8456933 [No Abstract] [Full Text] [Related]
7. Schistosomiasis. Proselytizing with immunity. Pearce EJ Nature; 1993 May; 363(6424):19-20. PubMed ID: 8097563 [No Abstract] [Full Text] [Related]
8. Vaccine development against schistosomiasis from concepts to clinical trials. Capron A; Capron M; Riveau G Br Med Bull; 2002; 62():139-48. PubMed ID: 12176856 [TBL] [Abstract][Full Text] [Related]
9. Prospects for immunological control of schistosomiasis. Dunne DW; Hagan P; Abath FG Lancet; 1995 Jun; 345(8963):1488-91. PubMed ID: 7769906 [No Abstract] [Full Text] [Related]
10. A vaccine for schistosomiasis: there is more. McManus DP Lancet; 1995 Jul; 346(8970):321-2. PubMed ID: 7630283 [No Abstract] [Full Text] [Related]
11. Opportunities and constraints in schistosomiasis vaccine development: infection characteristics and industry realities. Mitchell GF Mem Inst Oswaldo Cruz; 1995; 90(2):217-20. PubMed ID: 8531661 [TBL] [Abstract][Full Text] [Related]
12. Toward a complete immunity-inducing vaccine for schistosomiasis. El Ridi R J Parasitol; 2002 Oct; 88(5):1049-50. PubMed ID: 12435160 [No Abstract] [Full Text] [Related]
13. Still hope for schistosomiasis vaccine. Ricciardi A; Ndao M Hum Vaccin Immunother; 2015; 11(10):2504-8. PubMed ID: 26176659 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in vaccine research against schistosomiasis in Brazil. Oliveira SC; Fonseca CT; Cardoso FC; Farias LP; Leite LC Acta Trop; 2008; 108(2-3):256-62. PubMed ID: 18577363 [TBL] [Abstract][Full Text] [Related]
15. Vaccine development for schistosomiasis: report of a workshop. Hoffman DB; Phillips SM; Cook JA Am J Trop Med Hyg; 1981 Nov; 30(6):1247-51. PubMed ID: 7325283 [No Abstract] [Full Text] [Related]
16. Can anti-idiotype vaccine help to circumvent parasite escape mechanisms? Grzych JM; Del Guidice G; Capron M; Capron A; Lambert PH Monogr Allergy; 1987; 22():172-9. PubMed ID: 3437902 [No Abstract] [Full Text] [Related]
17. [Immunity in human schistosomiasis: hope for a vaccine]. Kouriba B; Traore B; Diemert D; Thera MA; Dolo A; Tounkara A; Doumbo O Med Trop (Mars); 2010 Apr; 70(2):189-97. PubMed ID: 20486361 [TBL] [Abstract][Full Text] [Related]
18. The WHO Collaborating Centre for Research and Control of Schistosomiasis at Niamey, Niger. Chippaux JP; Boulanger D; Brémond P; Campagne G; Véra C; Sellin B Mem Inst Oswaldo Cruz; 1997; 92(5):725-8. PubMed ID: 9566246 [TBL] [Abstract][Full Text] [Related]
19. The mouse model of schistosome immunity. Smithers SR; Simpson AJ; Yi X; Omer-Ali P; Kelly C; McLaren DJ Acta Trop Suppl; 1987 Jun; 12():21-30. PubMed ID: 2442986 [No Abstract] [Full Text] [Related]
20. The role of cercarial glycoproteins in immunization against mansoniasis infection of experimental animals. Salama MM; el-Ridi AM; Attia M; Aboul-Magd LA; Aronestein W; Strand M J Egypt Soc Parasitol; 1984 Dec; 14(2):343-51. PubMed ID: 6512285 [No Abstract] [Full Text] [Related] [Next] [New Search]